Equine Healthcare Market: Comprehensive Analysis and Forecast -2028

The global Equine Healthcare Market, categorized by Product Type (Drugs, Vaccines, and Medical Supplemental Feed), Disease Type, and Distribution Channel, underwent Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, spanning from 2021 to 2028.

Market Overview: In 2020, the global market stood at US$ 698.7 million, with an estimated Compound Annual Growth Rate (CAGR) of 4.3% projected from 2021 to 2028. By the end of 2028, it is expected to surpass US$ 972.8 million.

Download Sample Report@ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1603

Analysis of Market Scenario: Amid the COVID-19 pandemic, equine practitioners have implemented stringent biosecurity measures across farms, performance venues, and racetracks. However, recurring common horse healthcare issues have impeded market growth. To address this, stakeholders must enhance awareness regarding regular de-worming schedules and professional veterinary advice. Notably, corticosteroids and bisphosphonates like tiludronate disodium (Tildren) are widely used therapeutics, necessitating further research on their efficacy in young horses.

Revenue Opportunities from Comprehensive Vaccine Portfolio: Equine healthcare providers are conducting risk-benefit analyses to determine optimal vaccination strategies, emphasizing the importance of equine influenza and strangle vaccines. Moreover, manufacturers are developing anthrax vaccines for horses in high-risk areas and tailoring vaccines for pregnant mares. Expansion in vaccine portfolios, including equine herpesvirus and botulism vaccines, is observed.

Guidance from AVMA: The AVMA's recommendations during the pandemic prioritize the safety of equine veterinarians, advocating for a combination of control measures to minimize infection transmission. Telemedicine is increasingly adopted, and non-urgent procedures are rescheduled.

Have Any Query? Ask our Experts@ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=1603

Professional Intervention to Address Common Ailments: Market participants emphasize seeking professional veterinary advice to mitigate common horse healthcare issues like laminitis and thrush. The prevalence of allergies, colic, and mud fever underscores the demand for healthcare services, translating into revenue growth.

Early Detection through Wearable Technology: Apart from traditional interventions, research and development focus on equestrian sports technology, particularly wearables for horses. These devices facilitate early detection of healthcare issues by monitoring vital signs, presenting opportunities for med-tech companies.

Focus on Safety and Welfare: In the racing industry, medication regulations evolve to ensure fairness, horse safety, and public trust. Corticosteroids, NSAIDs, and bisphosphonates are key therapeutic agents, with racing regulators considering extending drug withdrawal periods to 48 hours pre-race.

Drivers and Challenges: The equine industry's economic significance, coupled with the prevalence of equine infections, drives market growth. However, a decline in the global equine population poses a challenge to market expansion.

Competition Landscape: The industry comprises global players like Bayer AG, Boehringer Ingelheim, and Zoetis. Strategies include regulatory approvals, technological advancements, and acquisitions to enhance market presence.

Market Segmentation: The market is segmented by product type (Drugs, Vaccines, and Supplemental Feed Additives), disease type, distribution channel, and region, offering comprehensive insights into regional dynamics and industry trends.

Enquire Before Buying@ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1603

Browse More Reports by TMR:

Peptide Therapeutics Market

https://www.globenewswire.com/en/news-release/2023/04/14/2647305/0/en/Peptide-Therapeutics-Market-Size-to-Hit-USD-91-25-Bn-by-2031-TMR-Study.html

Blood Testing Market

https://www.globenewswire.com/en/news-release/2023/04/14/2647267/0/en/Blood-Testing-Market-to-Reach-USD-218-2-Bn-by-2032-Growing-at-a-9-6-CAGR-TMR-Study.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.